Latest On Agilent Technologies, Inc (A):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2025-04-05 12:00 EST | Analyst Rating | The Analyst Target Price has increased from $139.5 to $151.06. | Buy |  |
| 2025-04-05 08:00 EST | Analyst Rating | The Analyst Target Price has increased from $139.5 to $151.06. | Buy | |
| 2025-04-05 04:00 EST | Analyst Rating | The Analyst Target Price has increased from $139.5 to $151.06. | Buy | |
| 2025-04-05 00:00 EST | Analyst Rating | The Analyst Target Price has increased from $139.5 to $151.06. | Buy | |
| 2025-04-04 20:00 EST | Analyst Rating | The Analyst Target Price has increased from $139.5 to $151.06. | Buy | |
About Agilent Technologies, Inc (A):
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and G read more...enomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California.
General
- Name Agilent Technologies, Inc
- Symbol A
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 16,400
- Last Split Factor1398:1000
- Last Split Date2014-11-03
- Fiscal Year EndOctober
- IPO Date1999-11-18
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryLife Sciences Tools & Services
- Gic SubIndustryLife Sciences Tools & Services
- Web URLhttp://www.agilent.com
Valuation
- Trailing PE 47.2
- Forward PE 31.95
- Price/Sales (Trailing 12 Mt.) 6.89
- Price/Book (Most Recent Quarter) 7.77
- Enterprise Value Revenue 6.96
- Enterprise Value EBITDA 29.23
Financials
- Most Recent Quarter 2021-01-31
- Current Year EPS Estimate $3.89
- Next Year EPS Estimate $4.35
- Profit Margin 15%
- Operating Margin 21%
- Return on Assets 8%
- Return on Equity 17%
- Revenue 5.53 billion
- Earnings Per Share $2.60
- Revenue Per Share $17.96
- Gross Profit 2.84 billion
- Quarterly Earnings Growth 14.1%
ESG Rating
Highlights
- Market Capitalization 37.35 billion
- EBITDA 1.46 billion
- PE Ratio 33.57
- PEG Ratio 2.45
- Analyst Target Price $139.5
- Book Value Per Share $15.76
Share Statistics
- Shares Outstanding 304.7 million
- Shares Float 303.75 million
- % Held by Insiders 32%
- % Held by Institutions 90.07%
- Shares Short 2.38 million
- Shares Short Prior Month 2.27 million
- Short Ratio 1.36
- Short % of Float 1%
- Short % of Shares Outstanding 1%
Technicals
- Beta 1.01
- 52 Week High $136.98
- 52 Week Low $61.59
- 50 Day Moving Average 122.85
- 200 Day Moving Average 113.59
Dividends
- Forward Annual Dividend Rate $0.78
- Forward Annual Dividend Yield 0.63%
- Payout Ratio 21%
- Dividend Date 2021-01-27
- ExDividend Date 2021-01-04
- Dividend Per Share $0.73
- Dividend Yield 0.65%
Agilent Technologies, Inc (A) Dividend Calendar:
Agilent Technologies, Inc pays an annual dividend of $0.78 per share, with a dividend yield of 0.65%.
A's last dividend payment was made to shareholders on January 27, 2021.
Agilent Technologies, Inc pays out 21% of its earnings out as a dividend.
Agilent Technologies, Inc (A) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Agilent Technologies, Inc (A) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Agilent Technologies, Inc (A) Chart:
Agilent Technologies, Inc (A) News:
Below you will find a list of latest news for Agilent Technologies, Inc (A) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Agilent Technologies, Inc (A) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest A Trades:
Agilent Technologies, Inc (A) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-11-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-30 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-30 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-13 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-01 | S-8 (Securities to be offered to employees in employee benefit plans) | |
| 2020-09-01 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-09-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-27 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-18 | 8-K (Current report) | |
| 2020-08-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-31 | 4/A (Statement of changes in beneficial ownership of securities) | |
| 2020-07-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-01 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-06-08 | 4 (Statement of changes in beneficial ownership of securities) | |
Agilent Technologies, Inc (A) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Agilent Technologies, Inc (A). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 32%
Institutional Ownership: 9007%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-11-04 | Michael Tang | SVP, General Counsel, and Sec. | Sell | 1,111.00 | 108.50 | 120,543.50 | 60,140.00 | |
| 2020-11-03 | Michael Tang | SVP, General Counsel, and Sec. | Sell | 1,111.00 | 106.43 | 118,243.73 | 61,251.00 | |
| 2020-11-02 | Michael Tang | SVP, General Counsel, and Sec. | Sell | 1,111.00 | 103.52 | 115,010.72 | 62,362.00 | |
| 2020-10-30 | Michael Tang | SVP, General Counsel, and Sec. | Sell | 3,333.00 | 101.77 | 339,199.41 | 63,473.00 | |
| 2020-10-09 | Dominique Grau | Senior Vice President | Buy | 6,485.00 | 39.12 | 253,693.20 | 104,153.87 | |
| 2020-10-09 | Dominique Grau | Senior Vice President | Sell | 6,485.00 | 105.00 | 680,925.00 | 97,668.87 | |
| 2020-08-31 | Dominique Grau | Senior Vice President | Buy | 6,485.00 | 39.12 | 253,693.20 | 104,153.87 | |
| 2020-08-31 | Dominique Grau | Senior Vice President | Sell | 6,485.00 | 100.00 | 648,500.00 | 97,668.87 | |
| 2020-08-25 | Rodney Gonsalves | V.P., Corporate Controller | Sell | 6,191.00 | 98.17 | 607,751.90 | 42,143.41 | |
| 2020-08-25 | Rodney Gonsalves | V.P., Corporate Controller | Buy | 6,191.00 | 40.80 | 252,592.80 | 48,334.41 | |
| 2020-08-03 | Hans Edgar Bishop | Director | Buy | 177.00 | 93.91 | 16,622.07 | 14,455.70 | |
| 2020-08-03 | Daniel K Podolsky | Director | Buy | 96.00 | 93.91 | 9,015.36 | 26,125.98 | |
| 2020-08-03 | GEORGE A SCANGOS | Director | Buy | 177.00 | 93.91 | 16,622.07 | 28,112.16 | |
| 2020-08-03 | Tadataka Yamada | Director | Buy | 212.00 | 93.91 | 19,908.92 | 58,374.23 | |
| 2020-07-30 | Michael R. McMullen | CEO and President | Sell | 72,716.00 | 95.76 | 6,963,575.02 | 502,499.14 | |
| 2020-07-30 | Michael R. McMullen | CEO and President | Buy | 72,716.00 | 39.12 | 2,844,649.92 | 575,215.14 | |
| 2020-06-04 | HEIDI FIELDS | Director | Sell | 10,392.00 | 91.00 | 945,661.61 | 0.00 | |
| 2020-05-27 | Rodney Gonsalves | V.P., Corporate Controller | Sell | 4,566.00 | 85.30 | 389,499.43 | 42,143.41 | |
| 2020-05-27 | Rodney Gonsalves | V.P., Corporate Controller | Buy | 3,100.00 | 40.80 | 126,480.00 | 46,709.41 | |
| 2020-05-26 | Jacob Thaysen | Sr. Vice President | Sell | 8,000.00 | 86.53 | 692,240.00 | 102,805.94 | |